2012年乌鲁木齐市肿瘤登记地区天山区恶性肿瘤发病分析

Analysis on the incidence of malignant tumor at TianShan District of Urumqi in 2012

目的探讨乌鲁木齐市肿瘤登记地区天山区恶性肿瘤的发病特征。方法资料来源于乌鲁木齐的肿瘤登记地区天山区上报的2012年肿瘤发病资料,根据《中国肿瘤登记工作指导手册》的肿瘤登记原则和方法,按年龄、性别、恶性肿瘤类型进行描述性分析。结果 2012年天山区恶性肿瘤新发病数1324例,发病率为190.15/10万。其中男性发病数629例,发病率为180.60/10万;女性发病数695例,发病率为199.72/10万,男女性别比为1.00：1.10,男女恶性肿瘤发病率差异无统计学意义（P﹥0.05）。恶性肿瘤发生主要分布在40~84岁年龄段。天山区最常见的5位恶性肿瘤分别为肺癌、乳腺癌、胃癌、结直肠癌、肝癌,占全部恶性肿瘤病例数的52.95%。其中男性恶性肿瘤发病率前5位依次是：肺癌、胃癌、肝癌、结直肠癌、前列腺癌,占男性恶性肿瘤病例数的63.28%;女性恶性肿瘤发病率前5位依次是：乳腺癌、肺癌、结直肠癌、宫颈癌、甲状腺癌,占女性恶性肿瘤病例数的56.40%。结论天山区恶性肿瘤发病率低于全国水平,不同性别、年龄发病率不同,需要积极采取预防癌症的有效措施,做到早发现,早诊断,早治疗。

Objective To investigate the epidemic characteristics of the cancer incidence from a cancer registration area： Tian Shan District of Urumqi. Methods The data of cancer incidence was collected from cancer registry in Tian Shan District of Urumqi in 2012.According to China Cancer Rigistration Guideline, age, gender, malignant tumor types were analyzed by descriptive analysis. Results There were 1324 new incidence cases including 629 male and 695 female in Tian Shan District in 2012. The cancer incidence was190.15/105（male 180.60/105, female 199.72/105）. The gender ratio was 1.00：1.10. There was no difference between male and female in cancer incidence（P﹥0.05）. The incidence of 40- 84 years old patients reached the highest level. The top 5 common cancers were lung cancer, breast cancer, gastric cancer, colon and rectum cancer, and liver cancer, accounting for 52.95% in all malignant tumors. For male,the top 5 common cancers were lung cancer, gastric cancer, liver cancer, colon and rectum cancer, and prostate cancer, accounting for63.28% in male malignant tumors. For female, the top 5 common cancers were breast cancer, lung cancer, colon and rectum cancer, cervix cancer and thyroid gland cancer, accounting for 56.40% in female malignant tumors. Conclusion The cancer incidence level in Tian Shan District was lower than that in our national other area. For cancer incidence in different genders and ages were different, efficient methods should be taken actively. By doing that, we can discover cancer earlier, diagnose cancer earlier and treat cancer earlier.